A diminutive protein prompts a closer look at DNA dark matter.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Novartis is taming nuclear power and putting it to use to treat advanced cancer.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.

Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.

For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

These stories offer a glimpse into the lives of people touched by a new era of medicine.